[Form 4] Dell Technologies Inc. Insider Trading Activity
Rhea-AI Filing Summary
Lynn V. Radakovich, a director of Dell Technologies Inc. (DELL), reported transactions dated 09/15/2025 executed under a Rule 10b5-1 trading plan adopted July 15, 2024. The filing shows the acquisition of 725 Class C common shares at $31.14 per share and a contemporaneous disposition of 725 Class C common shares at $126.39 per share, resulting in 23,680 Class C shares beneficially owned after the transactions.
The report also discloses 725 options to acquire Class C common stock with an exercise price of $31.14; the filer states the options are fully vested. Transactions were effected pursuant to the specified 10b5-1 plan and the Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Transactions effected under a Rule 10b5-1 plan, indicating pre-arranged trading and reduced likelihood of opportunistic timing
- Options are fully vested, clarifying exercisability status for the reported derivative holdings
- Form 4 filed with attorney-in-fact signature, showing formal execution of required disclosure
Negative
- Reported sale of 725 Class C shares at $126.39, reducing direct holdings by 725 shares
- Complexity in simultaneous acquisition and disposition may require investors to review filings for clarity
Insights
TL;DR: Insider used a pre-set 10b5-1 plan to exercise vested options and sell the same number of shares, producing a net reported share count change to 23,680.
The Form 4 shows a simultaneous acquisition at $31.14 and sale at $126.39 for 725 Class C shares executed under a Rule 10b5-1 plan. The disclosure that the options are fully vested clarifies exercisability. From a market-disclosure perspective this is a routine, pre-planned insider liquidity event rather than an ad hoc transaction, and it contains no additional operational or financial disclosures about Dell Technologies itself.
TL;DR: The filing documents compliance with Rule 10b5-1 and confirms vested option exercise; no governance issues are raised by the disclosure itself.
The Form 4 specifies the use of a trading plan adopted July 15, 2024, and an attorney-in-fact signature, indicating procedural adherence to insider-trading controls. The report does not state any amendment or irregularity. As filed, the disclosure is consistent with standard governance practices for planned insider transactions.